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Abstract: One Health is a collaborative, interdisciplinary effort that seeks optimal health for people, animals,
plants, and the environment. Toxoplasmosis, caused by Toxoplasma gondii, is an intracellular protozoan
infection distributed worldwide, with a heteroxenous life cycle that practically affects all homeotherms and in
which felines act as definitive reservoirs. Herein, we review the natural history of T. gondii, its transmission and
impacts in humans, domestic animals, wildlife both terrestrial and aquatic, and ecosystems. The epidemiology,
prevention, and control strategies are reviewed, with the objective of facilitating awareness of this disease and
promoting transdisciplinary collaborations, integrative research, and capacity building among universities,
government agencies, NGOs, policy makers, practicing physicians, veterinarians, and the general public.
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INTRODUCTION
Toxoplasmosis, caused by infection with the coccidian
Toxoplasma gondii, is a significant public health problem
worldwide. An estimated 8–22% of people in the USA are
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infected, and similar prevalence exists in the UK (Dubey
2002; Dubey and Jones 2008; Jones et al. 2001, 2003, 2007).
In Central America, South America, and continental Eur-
ope, estimates of infection range from 30 to 90% (Dubey
and Jones 2008; Dubey 2010; Minbaeva et al. 2013; Wilking
et al. 2016).
These infections have significant consequences affect-
ing mortality and quality of life. In the USA, where over a
million people are infected each year and approximately
2839 people develop symptomatic ocular disease annually,
the cost of illness has been estimated to be nearly $3 billion
and an 11,000 quality-adjusted life-year loss annually
(Jones and Holland 2010; Batz et al. 2012; Hoffmann et al.
2012). Mead et al. (1999) suggested that T. gondii is one of
three pathogens (along with Salmonella and Listeria) that
account for > 75% of all deaths due to foodborne disease
in the USA. Scallan et al. (2011) estimated that Toxoplasma
caused 8% of hospitalizations and 24% of deaths in the
USA resulting from foodborne illnesses.
As a global strategy, One Health recognizes the inter-
connectedness of the health of people, animals, plants, and
the environment from the local to the global levels and
employs a holistic approach encouraging and expanding
transdisciplinary collaborations, integrative research,
capacity building, clinical practice, policy, and communi-
cation among many stakeholders. This approach can
overcome bureaucratic boundaries and represents an
opportunity for new partnerships focused on solutions for
humans, animals, plants, and the environment (Zinsstag
2012; Rubin et al. 2014; Aguirre et al. 2016). Toxoplasmosis
qualifies as a One Health disease because it significantly
affects the health of human, domestic animals, wildlife, and
ecosystems, and is perceived as a threat by those who rely
on animal resources (Crozier and Schulte-Hostedde 2014;
Jenkins et al. 2015). The complicated relationships across
taxa are compounded by changing practices and attitudes
toward the control of owned and unowned (stray and feral)
outdoor domestic cats (Felis catus), which are the obligate
reservoirs of the parasite in urban and suburban settings,
where native wild felids are largely absent (Afonso et al.
2008).
New research on the impacts of toxoplasmosis (Ngo
et al. 2017; Suvisaari et al. 2017) increases the need for
greater institutional awareness of the pathways of infection
and comprehensive and transdisciplinary actions to control
transmission using the One Health approach. Such coop-
eration has thus far been elusive, perhaps in part to a lack of
familiarity with the biology of T. gondii or its significant
adverse impacts on health (Efunshile et al. 2017). Herein,
we review the natural history of T. gondii, its transmission
and impacts, and suggest approaches that could help pro-
tect human, domestic animal, wildlife, and ecosystem
health, with the goal of facilitating a better understanding
of this disease and promoting transdisciplinary collabora-
tions, integrative research, and capacity building among
universities, government agencies, NGOs, policy makers,
physicians, veterinarians, and the general public.
NATURAL HISTORY OF TOXOPLASMA GONDII
Toxoplasma gondii is a member of the Apicomplexa, a di-
verse group of parasitic protozoans including Babesia,
Cryptosporidium, Cyclospora, Isospora, and Plasmodium
(Kim and Weiss 2004). It was first isolated from a common
gundi (Ctenodactylus gundi) in Tunis in 1908 and the same
year in a rabbit from South America. Six clades have been
characterized using population genetic structure studies
indicating that globally diverse isolates originate from a
small number of ancestral lineages (Su et al. 2012). It is
postulated that T. gondii originated in South American
felids with relatively recent expansion through migratory
birds and in particular the transatlantic slave trade that
promoted migration of domestic cats, rats, and mice
(Lehmann et al. 2006). Three predominant archetypal
clonal lineages of T. gondii have been identified (Howe and
Sibley 1995; Ajzenberg et al. 2004; Darde´ 2004; Saeij et al.
2005). Diverse atypical genotypes have also been found in
the Americas and China (Miller et al. 2008; Khan et al.
2011; Chaichan et al. 2017). Shwab et al. (2014) used 10
PCR–RFLP markers to classify 1457 T. gondii specimens
into 189 genotypes, most of which fell into genotypes 1
through 5. Although no dominant genotype has been
found in the southern hemisphere, a few genotypes were
predominant in the northern hemisphere, specifically
genotypes 1 (type II clonal), 2 (type III), and 3 (type II
variant), which comprise the majority of isolates and are
prevalent in Europe. Genotypes 2 to 5 (4 and 5 collectively
known as type 12, and prevalent in wildlife) are common in
North America. Genotypes 2 and 3 predominated in Africa,
whereas genotypes 9 and 10 were highly prevalent in China
(Wendte et al. 2011; Shwab et al. 2014; Chaichan et al.
2017). Certain genotypes are associated with increased
virulence in humans and wildlife (Sibley and Boothroyd
1992; Miller et al. 2004; Carme et al. 2009; Xiao and Yolken
2015). Lorenzi et al. (2016) compared the genomes of 62
The One Health Approach to Toxoplasmosis: Epidemiology 379
globally distributed isolates, identifying that T. gondii is
characterized by clade-specific inheritance of large con-
served haploblocks with different ancestries that may
influence transmission, host range, and pathogenicity.
Clonal lineages 1–4 are extremely abundant, with highly
similar multilocus genotypes, high levels of linkage dise-
quilibrium, and infrequent recombination.
The parasite can only sexually reproduce and, thereby,
complete its life cycle in felids, which are definitive hosts
capable of excreting massive numbers of oocysts into the
environment via feces (Frenkel 1973). Oocysts will sporu-
late to contain infectious sporozoites. If as few as a single
sporulated oocyst is ingested or inhaled by an intermediate
host, including all classes of warm-blooded (homeotherm)
vertebrates, T. gondii may then reproduce asexually in the
host’s tissues (Miller et al. 1972; Dubey et al. 1996). Asexual
reproduction results in the formation of tachyzoites and
bradyzoites from sporozoites. While bradyzoites form tis-
sue cysts in the intermediate host, tachyzoites invade many
host tissues to include the heart, lung, and central nervous
system and will spread by intrauterine infection and
transplacental migration to infect the fetus; (Georgi 1985;
Markell 1986). The life cycle is completed when the tissues
of an intermediate host are consumed by a cat, and sexual
reproduction in the definitive host may begin again
(Fig. 1). One of the ways by which T. gondii facilitates the
completion of its life cycle is host manipulation. Infected
rodents, for example, lose their innate fear of cats and
demonstrate an attraction to cat urine (Berdoy et al. 2000;
Vyas et al. 2007). Host manipulations associated with T.
gondii infection have also been observed or hypothesized in
other taxa, including primates and birds (Poirotte et al.
2016; Work et al. 2016).
Toxoplasmosis in Humans
Toxoplasmosis is the second leading cause of death among
foodborne illnesses in the USA (Scallan et al. 2011; Gao
et al. 2016). In humans, symptoms, or lack thereof, at the
time of infection do not predict disease manifestation later
in life. The disease may be either acute or chronic and can
cause active infection at any age (Boyer et al. 2011; Delair
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Figure 1. Life cycle of Toxoplasma gondii and transmission in humans, domestic animals, wildlife and ecosystems
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et al. 2011). Postnatal T. gondii infection may appear to be
asymptomatic or cause fever and lymphadenopathy
(Montoya and Remington 1995) and affect any organ,
especially the eyes (Delair et al. 2011; Undseth et al. 2014),
and cause seizures (McAuley et al. 1994). Virulence varies
by strain and susceptibility based on an individual’s genetic
traits (Ngo et al. 2017). Genotypes in French Guiana, for
example, cause significant damage and even death in adults
who are not known to be immunocompromised (Carme
et al. 2009). In the USA, an estimated 1.1 million people are
infected with T. gondii each year, and approximately 10.4%
of the population demonstrate seroprevalence linked to
past exposure (Jones and Holland 2010; Jones et al. 2018).
Initial infection acquired by pregnant women may
cross the placenta and reach the fetus (McLeod et al. 2014).
Toxoplasma tachyzoites multiply and invade fetal tissues to
cause acute or chronic disease (Markell 1986). This con-
genital infection may be systemic and result in fetal death,
premature birth, intrauterine growth retardation, fever,
pneumonia, hepatosplenomegaly, thrombocytopenia, or
involve the eyes and brain (McAuley et al. 1994; Peyron
et al. 2016). Manifestations of ocular or encephalic disease
in the fetus may include chorioretinitis, meningoen-
cephalitis, hydrocephaly, microcephaly, or calcifications of
previous areas of necrosis; however, infants generally do
not show clinical signs at birth and instead may become
deaf later in life. When women acquire the infection more
than 6 months prior to gestation, risk of transmission to
the fetus is considerably reduced. Although preventable and
treatable, congenital, ocular, and postnatal T. gondii
infection is not curable and persists in all infected persons
(Ortiz et al. 2013; Peyron et al. 2016; Ngo et al. 2017).
Latent or primary toxoplasmosis can be particularly dan-
gerous in individuals with compromised immune systems,
including those treated with corticosteroids, cytotoxic
medicines, and antibody to tumor necrosis factor alpha
(Lykins et al. 2016; Wang et al. 2017). Approximately one
third of HIV-infected individuals with T. gondii infection
develop encephalitis (Walker and Zunt 2005).
Retinal toxoplasmosis (Kianersi et al. 2012) is recog-
nized as a major cause of blindness in many parts of the
world (Balasundaram et al. 2010). About 5000 people de-
velop ocular toxoplasmosis in the USA annually (Jones and
Holland 2010). Chronic infections, previously believed to
be benign, are now a source of increasing concern. Evi-
dence of exposure to T. gondii has been associated with
cognitive decline in older individuals (Gajewski et al. 2014)
and increased disease overall (Flegr et al. 2014). Further-
more, such serological evidence of T. gondii is associated
with a range of neuropsychiatric disorders including
schizophrenia (Torrey and Yolken 2003; Yolken et al.
2009), depression, suicide attempts (Arling et al. 2009;
Flegr et al. 2014), and anxiety disorders. The mechanisms
that define these associations are not known with certainty
but may be related to the immune response to the tissue
cysts and presence of bradyzoite tissue cysts within the
brain following infection (Xiao et al. 2016).
Recent studies have demonstrated that undetected
environmental oocyst transmission is the major route of T.
gondii transmission presenting a direct public and animal
health problem (Tenter et al. 2000, Dabritz and Conrad
2010, Boyer et al. 2011, Hill et al. 2005, 2011, Torrey and
Yolken 2013; VanWormer et al. 2016). The risk factors for
human and animal infection include consuming infected
raw or undercooked meat; ingestion of contaminated wa-
ter, soil, vegetables, or anything contaminated with oocysts
shed in feces; blood transfusion or organ transplants;
intrauterine or transplacental transmission; and drinking
infected unpasteurized milk. The majority (78%) of con-
genital toxoplasmosis cases from four epidemics in North
America originated from oocyst exposure, though only
49% of these cases could be confirmed as foodborne. Two
public health studies in Chile evaluated oocyst-acquired
infections in pregnant women and in swine, which are a
primary food source; T. gondii oocyst-specific IgG anti-
bodies were determined in 193/490 (43%) of serum sam-
ples from pregnant women and in 24/30 (80%) of 30/340
(8.8%) the swine (Mun˜oz-Zanzi et al. 2010, 2012). Oocysts
can also contaminate drinking water sources, both small-
scale wells (Sroka et al. 2006) and larger reservoirs (Bowie
et al. 1997), and can contaminate surfaces, such as dog fur
(Frenkel et al. 2003) or keypads (Bik et al. 2016).
Toxoplasmosis in Domestic Animals
Despite a high global prevalence, infected domestic cats
typically are asymptomatic and do not have recognizable
clinical disease (Hill and Dubey 2014). Nevertheless, clin-
ical signs may include fever, ocular inflammation, anorexia,
lethargy, pneumonia, abdominal discomfort, and central
nervous system disturbances (Vollaire et al. 2005; Dubey
and Jones 2008). Clinical infection is most severe in kittens,
and feral domestic cats are at a higher risk of infection than
indoor cats (Dubey and Jones 2008).
Domestic dogs may also be infected with T. gondii;
however, clinical infection is less common than subclinical
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disease (Dubey et al. 2009; Hill and Dubey 2013). When
manifested, clinical signs may affect respiratory, neuro-
muscular, or gastrointestinal systems and can prove fatal
(Dubey et al. 2009). Free-roaming dogs are believed to be at
higher risk, though dogs may become infected within
households by eating uncooked infected meat (Cabezo´n
et al. 2010).
Toxoplasmosis is common in sheep, goats, pigs, and
chickens as intermediate hosts; however, cattle and horses
are notably resistant to the disease. In sheep, congenital
infection is a leading cause of stillbirth and preterm lamb
loss. Lambs that are born infected and survive usually ex-
hibit normal growth, but they still represent a public health
risk if their infected meat is consumed (Dubey 2009).
Toxoplasmosis can also occur in adult goats, and the dis-
ease is more severe than in sheep. Congenital infection
results in loss of kids before or after birth. Pigs may become
infected with T. gondii by consumption of oocysts, con-
genitally by tachyzoite transplacental transmission, and
through consumption of meat containing T. gondii
bradyzoite tissue cysts. Although adult pigs rarely show
clinical signs, the meat of infected pigs serves as a source of
human infection; young pigs can die from toxoplasmosis
without entering the human food chain. Animal infections
with T. gondii appear to be largely driven by environmental
exposure to the oocysts, and the presence of outdoor
domestic cats has been identified as risk factor for infection
in farm animals (Vesco et al. 2007). Consequently, non-
confinement livestock housing and facilities lacking ade-
quate biosecurity and pest management practices represent
significant risk factors for livestock infection (Dubey and
Jones 2008; Hill and Dubey 2016).
Toxoplasmosis in Wildlife
Toxoplasmosis is a global disease found in all habitats and
regions, from the Arctic to the tropics in terrestrial, aquatic,
and marine settings affecting all homeotherms (Sibley
2003). The number of documented infected species is
extensive (e.g., Dubey and Jones 2008; Dubey 2010).
Detection in apparently healthy, free-ranging wildlife sug-
gests that asymptomatic or subclinical infections may oc-
cur. Pathways for wildlife infection include consumption of
infected felids, predation or scavenging of infected inter-
mediate hosts, direct ingestion of oocysts in the contami-
nated environment, and congenital transmission by
transplacental transmission of tachyzoites from the infected
parent (Fig. 1). Environmental transmission to carnivores
and omnivores such as polar (Ursus maritimus), grizzly
(Ursus arctos), and black bears (Ursus americanus) can be
driven by either consumption of infected meat in prey
species or direct ingestion of oocysts (Chomel et al. 1995;
Oksanen et al. 2009).
Depending on their geographic range, serologic studies
in herbivores correlate with density of domestic cats linked
to oocyst density (Fredebaugh et al. 2011). For example,
Hawaiian geese (Branta sandvicensis) have seroprevalences
of 21–48% as a result of exposure to oocysts (Work et al.
2016). Other terrestrial, wild herbivores infected by T.
gondii include white-tailed deer (Odocoileus virginianus),
with reported seroprevalence of 49.5% in suburban areas
and 66.1% in urban areas, indicative of a greater prevalence
of oocysts in the soil as domestic cat densities increase with
human populations (Le´lu et al. 2010; Dubey et al. 2014;
Ballash et al. 2015).
Infection in marine mammals is geographically and
taxonomically widespread, driven by land-to-sea coastal
oocyst pollution linked to oocysts from storm water runoff
(Cole et al. 2000; Dubey et al. 2003; Littnan et al. 2006;
Aguirre et al. 2007; Lindsay and Dubey et al. 2009; Oksanen
et al. 2009; Jensen et al. 2012; Rengifo-Herrera et al. 2012).
The threatened southern sea otter (Enhydra lutris nereis),
exposed through the consumption of invertebrate prey,
(Johnson et al. 2009; Shapiro et al. 2014), serves as a sentinel
of the land-to-sea flow of T. gondii oocysts originating from
runoff carrying infected domestic or wild felid fecal matter
(Jessup et al. 2004; Conrad et al. 2005). This route of exposure
has been confirmed for other marine mammals (Miller et al.
2002, 2008; Conrad et al. 2005). Similar genotypes have been
detected in tissues from sea otters, terrestrial wildlife, i.e.,
bobcats, mountain lion, and wild canids, and feral domestic
cats sharing the California coast (Miller et al. 2008; Van-
Wormer et al. 2014; Verma et al. 2017).
Aquatic invertebrates may significantly influence
waterborne transport of Toxoplasma, by enhanced settling
and subsequent benthos concentration, and by facilitating
ingestion by invertebrate vectors that can transmit the
infective stage to susceptible hosts, including marine
mammals and humans. Recent studies by Shapiro et al.
(2014) have demonstrated the critical role of invisible
polymers in transmission of T. gondii in food webs through
particle aggregates and biofilms increasing the retention of
the parasite in snails grazing on kelp and facilitating
infection of California sea otters.
Land-to-sea coastal exposure has resulted in fatal
toxoplasmosis in phocids, otariids, mustelids, and ceta-
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ceans, negatively impacting some threatened and endan-
gered populations (Holshuh et al. 1985; Inskeep et al. 1990;
Migaki et al. 1990; Jardine and Dubey 2002; Dubey et al.
2004; Carlson-Bremer et al. 2015; Barbieri et al. 2016). Yet
data on mortality in marine mammals are limited to those
obtained through necropsies of stranded animals. More
animals die than are found dead every year, particularly for
offshore and migratory taxa; hence, the number of affected
marine mammals is likely underrepresented.
Toxoplasmosis in Ecosystems
Domestic cats are likely the major source of ecosystem
contamination in many areas due to their high abundance
on the landscape relative to native felids (VanWormer et al.
2013). A large percentage of domestic cats in the USA may
carry T. gondii during their lifetime (Tenter et al. 2000),
and each infected cat sheds up to hundreds of millions of
oocysts (Dubey 1996), with the high probability that any
location with free-roaming cats will become contaminated
with oocysts (Torrey and Yolken 2013). Each oocyst may
remain infectious for months to years (Tenter et al. 2000;
Le´lu et al. 2012). Dabritz et al. (2007) estimated that
owned, domestic cats in Morro Bay, California, annually
deposited 77.6 tons of feces and that free-roaming cats in
the same area deposited 30 tons of feces, resulting in an
estimated annual oocyst loading of over 4500 oocysts/m2.
The greater the number of cats, the greater the accumula-
tion of oocysts, and, presumably, the greater the probability
of transmission to humans, other domestic animals, and
wildlife.
An estimated 30–80 million feral domestic cats exist in
the USA (Loss et al. 2013); all of which defecate outdoors,
and each of which are at a much higher risk of hosting and
spreading T. gondii (Dubey 2010; VanWormer et al. 2013).
Unlike with other domestic animals (e.g., domestic dogs),
many states do not address who or what entity is respon-
sible for unowned and feral domestic cats. A patchwork of
local or nonexistent regulations may increase confusion,
hampering the ability to control domestic cats even on
one’s own property. This regulatory confusion, combined
with the efforts by some private organizations to eliminate
all euthanasia for animal control (Longcore et al. 2009;
ASPCA 2017), has contributed to the establishment of
programs and policies that preserve unowned and feral
domestic cats on the landscape. Such programs remain in
place despite calls for the removal of unowned and feral
domestic cats from the environment for a variety of reasons
(e.g., public health, wildlife conservation, animal welfare)
from numerous professional organizations and government
agencies and evidence of public support (Levy and Craw-
ford 2004; Lohr and Lepczyk 2014). Public opposition to
removal policies may be partially influenced by misinfor-
mation that minimizes the risks of toxoplasmosis and
downplays the role of domestic cats as vectors for disease
transmission in many ecosystems as documented in the
scientific literature (Loss and Marra 2018).
Animal sheltering policies can influence the risk of T.
gondii transmission by affecting the number of free-roam-
ing domestic cats. Management policies that remove cats
from ecosystems reduce environmental transmission risks
by eliminating the interaction of definitive and intermedi-
ate hosts. Conversely, policies that intentionally maintain
unowned and feral domestic cats on the landscape facilitate
and may increase the risk of disease transmission. As a
growing number of municipalities and their animal shelters
adopt policies that purposely maintain domestic cats
unconfined outdoors (Holtz 2014), T. gondii transmission
risks for people, domestic animals, and wildlife increase.
A better understanding of the environmental abun-
dance of oocysts is critical to holistic determinations of
health risks. Studies indicate that large regions of terrestrial,
aquatic, and marine environments may be contaminated
(Du et al. 2012a, b; Gao et al. 2016; VanWormer et al.
2013). T. gondii is known to be influenced by environ-
mental conditions, and survival of oocysts in the soil may
be influenced by geological and environmental character-
istics such as soil temperature, texture, and chemistry
(Frenkel et al. 1975; Lindsay and Dubey 2009; Le´lu et al.
2012). Broader environmental sampling of oocysts in soil
and stormwater runoff should be undertaken and modeled
by land use, feline density, and animal shelter policies. The
environmental parameters responsible for long-term sur-
vival and resistance of oocysts, regional extent of environ-
mental contamination with oocysts, and duration of
survival or infectivity of tissue cysts following host death
are poorly understood and require additional research. The
ubiquity of T. gondii oocysts in the environment increases
the likelihood of infection for all at-risk species in the
ecosystem. Perhaps the most important ecosystem man-
agement tool is to control contaminated runoff to mitigate
the health impacts of coastal habitat pathogen pollution.
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ENVISIONING A ONE HEALTH RESPONSE
One Health focuses on transdisciplinary collaborations to
solve issues across human health, animal and plant health,
and the environment. Accordingly, for the near- and long-
term future, One Health has little choice but to engage in
the study, mitigation, and prevention of daunting chal-
lenges (Aguirre et al. 2016). Critical to One Health will be
effective monitoring of toxoplasmosis and T. gondii
prevalence. In the USA, toxoplasmosis is not a nationally
reportable disease and, thus, its true magnitude is unknown
(Jones et al. 2001; Torgerson and Mastroiacovo 2013).
Likewise, although the burden of toxoplasmosis in other
countries like Brazil is very high, we can only hypothesize,
for example, the incidence of congenital disease in children
(Dubey et al. 2012). Although some screening of pregnant
women and newborns exists in the USA, these programs
are largely absent and fall behind the regular screening in
many countries (Peyron et al. 2017). Furthermore,
screening programs associated solely with congenital tox-
oplasmosis may miss large segments of the infected popu-
lation. Enhanced screening programs would deliver greater
data that can be used to develop more responsive tools for
risk reduction. Integrating human, domestic animal, and
wildlife data could better assess risk and devise methods of
control.
Current patterns of human-driven environmental
change and globalization of travel and trade can enhance
the spillover and spillback of Toxoplasma and parasites of
animal origin into human populations, introduce patho-
gens into critically endangered animal populations, and
further facilitate propagation locally, regionally, and glob-
ally. The odds of an infectious disease pandemic have never
been higher. Furthermore, given that most emerging
infectious diseases in humans are of animal origin (zoo-
notic), there is a pressing need to integrate human–animal–
ecosystem health within a common framework. The recent
convergence of global problems, including global environ-
mental change, biodiversity loss, habitat fragmentation,
globalization, and infectious disease emergence, demands
integrative approaches breaching disciplinary boundaries
leading to ‘‘One Health.’’ This integration requires com-
mitment not only from government agencies, universities,
and other organizations but eventually will attempt to
generate new international structures (Aguirre 2011; Gor-
tazar et al. 2014; Suza´n et al. 2015).
Transdisciplinarity
Simple solutions are rarely evident in addressing regional
or global ecological and environmental problems. A multi-
pronged, transdisciplinary, One Health approach is re-
quired in infectious disease ecology. For example, this ap-
proach has been used in echinococcosis in North America
(Massolo and Liccioli 2016); during evaluation of rabies
control programs in Sri Lanka (Ha¨sler et al. 2014); during
parasitic zoonosis surveillance in Australian wildlife
(Thompson 2013); and in foodborne diseases resulting
from Cryptosporidium spp., Giardia duodenalis, Cyclospora
cayetanensis, and T. gondii, in developed countries (Dixon
2016); in the past 10 years, new tools and institutional
initiatives for assessing and monitoring emerging patho-
gens have been developed. Landscape epidemiology, disease
ecological modeling, and web-based Google analytics have
emerged. New types of integrated ecological health assess-
ment are being deployed; these efforts incorporate envi-
ronmental indicator studies with specific biomedical
diagnostic tools. Other innovations include the develop-
ment of noninvasive physiological and behavioral moni-
toring techniques, the adaptation of modern molecular
biological and biomedical techniques, the design of popu-
lation-level disease monitoring strategies, the creation of
ecosystem-based health and sentinel species surveillance
approaches, and the adaptation of health monitoring sys-
tems for appropriate low-income country situations. Ulti-
mately, a data-driven decision support tool must be created
to help practitioners and managers devise choices for action
and intervention. Epidemiologists, modelers, public health
officials, veterinarians, and sociobiologists need to employ
strong inference techniques including model selection,
disease inference techniques, to apply a rigorous approach
to establishing causation in disease ecology (Azeez and
Prabhakar 2016). Mathematical modeling, predictive tools,
and novel prevention strategies of emerging infectious
diseases have evolved enormously in the last decade. These
exciting tools now allow for improved characterization and
prediction of disease dynamics and disease behavior (Vi-
netz et al. 2005; Aguirre et al. 2016; Guo et al. 2016).
Toxoplasma gondii is known to be influenced by
environmental conditions, and measures to mitigate
exposure can affect ecosystem health. The environmental
parameters responsible for long-term survival and resis-
tance of the parasite in oocyst form or the duration of
survival or infectivity of tissue cysts from an infected ani-
mal that dies in the field are poorly understood. Filling
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these science and knowledge gaps will require effective,
truly transdisciplinary collaborations involving scientists
from a broad spectrum of disciplines including but not
limited to earth, environmental, biological, ecological, so-
cial, engineering, and health sciences, and their many
subdisciplines (Aguirre and Wilcox 2008).
Integrative Research
Research is needed to integrate data across scales to assess
risk and devise methods of control, as links are made be-
tween toxoplasmosis and significant adverse health out-
comes beyond acute infection in humans, i.e., congenital
infection, increased death rates in traffic accidents (Flegr
et al. 2002, 2009), and environmental transmission rather
than meat consumption emerges as a significant pathway
for infection (Dabritz and Conrad 2010; Boyer et al. 2011;
Hill et al. 2011; Torrey and Yolken 2013). Soil sampling for
oocysts has been undertaken around the world and needs
to be expanded and modeled by land use and outdoor cat
management policies to understand risk. Relationships of
policies for animal sheltering and outdoor cat density and
resulting oocyst loads are foreseeable but require integrative
research. Such research efforts will require transdisciplinary
teams to integrate field and laboratory methods, spatial,
geographic, and other mathematical modeling, and veteri-
nary and medical practices.
Future research should also focus on vaccine devel-
opment. A vaccine is available for sheep in some countries,
but no vaccine exists for other livestock, humans, or
wildlife. A vaccine for domestic cats was produced, but its
implementation has been limited by high costs of pro-
duction, short shelf life, and lack of interest from domestic
cat owners (Dubey 2010). The development of a vaccine, as
well as more effective therapies for the long-term effects of
tissue cysts in the brain, eye, and other vital organs, remain
important goals. Such research would also benefit efforts to
conserve highly endangered species in the wild that are at
risk from death from toxoplasmosis (Work et al. 2016).
The increasing demand for food safety together with
the potential economic impact of legislation aimed at risk
reduction has brought attention to the need for the
development and standardization of diagnostic tests for
Toxoplasma infection. Such tests will need to provide an
accurate estimate of risks of transmission of toxoplasmosis
to humans and must perform with comparable specificity
and sensitivity across a range of animal species. Despite the
lack of widespread, effective screening processes are in place
for consumer meats, with new standardized tests which
may be useful for disease monitoring and control (Nunes
Mecca et al. 2011).
Building Local Capacity
A key component of a One Health response to toxoplas-
mosis must include greater communication of the risks and
pathways of exposure to T. gondii. Human and veterinary
health practitioners, as well as all professionals interacting
with the public, should seek to more effectively explain
current understandings of the life history, transmission
routes, and best practices for avoiding exposure. For
example, while acknowledging the risks of infection
through consumption of tissue cysts, the risks of oocyst
exposure should not be downplayed. Outdoor cats should
be prevented from accessing community gardens as a food
biosecurity issue and exclude cats from any location where
food is grown. Children should avoid areas where cat feces
may be found, domestic cat access to the outdoors should
be limited, and steps taken to reduce the number of free-
roaming domestic cats and the associated number of T.
gondii oocysts.
Widespread participation, especially with human and
veterinary health practitioners, is necessary to stem the
societal and ecosystem impacts of toxoplasmosis. Doctors,
public health specialists, veterinarians, and even wildlife
biologists should know to caution the public to always
wash hands after working in any soil where cat feces may be
found, exclude cats from any location where children or
others play in a manner that might lead to hand-to-mouth
contact with contaminated soil, and take steps to reduce
the number of free-roaming domestic cats on the land-
scape. Children should be taught to wash their hands
thoroughly after touching a pet that has access to the
outdoors.
Local capacity also includes a commitment to laws to
control the number of feral domestic cats on the landscape
to minimize the risk of transmission of T. gondii. Current
discussions surrounding animal sheltering, as discussed
above, often dismiss this risk as minimal and almost never
incorporate the clear society-level impacts from chronic
infection that have now been shown in the literature for
over a decade. Veterinary schools have a particular
responsibility to educate their students on the risks of this
disease and not to allow specialized programs with outside
funding, e.g., ‘‘shelter medicine’’ programs funded by ani-
mal rights organizations, to put out messages that under-
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mine established science. Such changes will be difficult,
given that promoting unowned free-roaming domestic cats
as perfectly acceptable features of the landscape has gar-
nered significant funding. Progress to address this situation
can come from a transdisciplinary, integrative approach
that considers the substantial advances in research on T.
gondii of recent years. In addition, controlling the feral cat
population will have a positive conservation outcome for
wildlife. For example, annual mortality of wild birds in the
USA reaches 2.4 billion and 204 million in Canada due to
feral cat predation, increasing the probability of population
extinction or decline for some bird species. In addition,
6.3–22.3 billion mammals are killed each year in the USA
(Loss et al. 2013, 2015). Comprehensive and sound policies
and control interventions based on science are required to
reduce these astronomical impacts.
CONCLUSIONS
One Health has emphasized the need to bridge disciplines
linking human health, animal health, and ecosystem health.
Toxoplasmosis demands integrative approaches breaching
disciplinary boundaries. This integration is needed to
generate new approaches to manage and control the dis-
ease. The complexity of toxoplasmosis requires the devel-
opment of a dashboard system of measures that are a
combination of health and ecological indicators, that is, an
easy set of indicators for quick reference to identify pre-
vention and management needs.
Transdisciplinarity, integrative research, and capacity
building are core elements in establishing One Health
interventions that address toxoplasmosis. Innovative par-
ticipatory methodologies that operationalize knowledge
flow among stakeholders should consensually and sus-
tainably address this major problem confronting society,
wildlife, and ecosystems globally (Aguirre et al. 2019). The
One Health approach to toxoplasmosis epidemiology and
control requires practical, sustainable, and effective solu-
tions with a keen understanding of local socioeconomic
and cultural factors as well as a solid grasp of complex local,
regional, national, and international health and environ-
mental policies. One Health offers time-sensitive oppor-
tunities for practitioners to apply their expertise to give rise
to simultaneous benefits for humans, animals, and the
environment.
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